What You Should Know:
– myTomorrows, a global health technology company connecting patients with all possible pre-approval treatment options, today announced a new partnership with Patients Know Best (PKB), a social enterprise and the leading personal health record platform in the UK.
– The collaboration will enable UK patients with unmet medical needs to access their health records and conduct more efficient searches for further treatment options.
Revolutionizing Patient Access to Pre-Approval Treatments: myTomorrows’ AI-Powered Search Platform
myTomorrows is a global healthtech company dedicated to eliminating barriers for patients seeking treatment options. Utilizing a proprietary technology, the company conducts comprehensive searches of clinical trials and, where applicable, Expanded Access Programs (EAPs) from global public registries. This innovative approach connects patients, physicians, trial sites, and BioPharma, streamlining access to drugs in development. Headquartered in Amsterdam with an office in New York City, myTomorrows has facilitated treatment access for over 14,000 patients and 2,200 physicians across more than 200 sites in 125+ countries.
Partnership with Patients Know Best (PKB)
- Secure Patient Data Sharing: Patients can consent to securely share their PKB medical records with myTomorrows for a personalized clinical trial search.
- AI-Powered Search & Navigation: Using patient-provided data, myTomorrows identifies relevant pre-approval treatments, including clinical trials and EAPs, through its free AI-driven platform and Patient Navigation services.
- Addressing Fragmented Health Records: Patient data is often fragmented across clinician consultations, hospital visits, wearable devices, and medication lists, making it difficult to access a complete medical history. The UK government recognizes the need for better synchronization in its NHS 10-year plan.
- Streamlined Access to Treatment Options: UK patients with PKB profiles (integrated with the NHS App) can efficiently explore pre-approval treatments for unmet medical needs, empowering them with data-driven decision-making.
Enhancing Clinical Trial Accessibility
- Comprehensive & Unbiased Search Tool: myTomorrows’ platform sources clinical trial data from trusted, WHO-endorsed registries, including clinicaltrials.gov, EudraCT, and ISRCTN.
- Time-Saving Data Integration: Instead of manually compiling medical records, patients can consent to share PKB data with myTomorrows’ Patient Navigator team, ensuring accurate and up-to-date searches.
- Personalized Treatment Overview: The Patient Navigator team generates a tailored trial search summary, identifying pre-approval treatments for which the patient may be eligible.
- Collaborative Decision-Making: Patients and their clinicians can review and discuss potential treatment options, with myTomorrows providing support in accessing them.
Unifying Patient Data for Improved Care
- Real-Time Data Integration: PKB consolidates information from hospitals, GPs, social care, and mental health IT systems, along with patient-contributed data, into a unified record.
- Continuous Accessibility: Aggregated PKB data remains accessible to patients, caregivers, and healthcare professionals, regardless of location.
- Empowering Self-Care & NHS Efficiencies: By equipping patients with comprehensive health data, PKB enhances self-care and drives broader efficiencies within the NHS.
Leadership Perspective
“It is a privilege to partner with Patients Know Best, an organization that values patient-centricity as much as myTomorrows,” said Dr. Michel van Harten, CEO of myTomorrows. “When standard care no longer meets a patient’s medical needs, finding alternative solutions can be overwhelming. Through this collaboration, we aim to simplify the process, providing patients, their families, and healthcare professionals across the UK with a streamlined approach to identifying next steps in their treatment journey.”
By integrating AI-driven technology with seamless data sharing, myTomorrows and PKB are transforming patient access to pre-approval treatments, ensuring timely and informed decision-making for those in need.
